A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma

Bone Marrow Transplant. 2024 May;59(5):695-698. doi: 10.1038/s41409-024-02231-4. Epub 2024 Feb 14.

Asao Hirose¹, Hideo Koh^{1

2}, Mika Nakamae^{1

3}, Yasuhiro Nakashima¹, Mitsutaka Nishimoto¹, Hiroshi Okamura^{1

3}, Yosuke Makuuchi¹, Masatomo Kuno¹, Teruhito Takakuwa¹, Kentaro Ido^{1

3}, Kazuki Sakatoku¹, Masayuki Hino^{1

3}, Hirohisa Nakamae⁴

¹ Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
² Department of Preventive Medicine and Environmental Health, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
³ Department of Laboratory Medicine and Medical Informatics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
⁴ Department of Hematology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. hirohisa@omu.ac.jp.

No abstract available

Publication types